2017
DOI: 10.1159/000479265
|View full text |Cite
|
Sign up to set email alerts
|

The Place of Large Pore Membranes in the Treatment Portfolio of Patients on Hemodialysis

Abstract: Cardiovascular disease is a major concern in patients with end-stage kidney disease (ESKD). Inflammation induced by retention of uremic toxins, of which a substantial fraction has a molecular weight in the middle molecular range, has been associated with increased cardiovascular risk. In an attempt to reduce inflammation and thus cardiovascular toxicity in patients with ESKD, hemodiafiltration (HDF) has been promoted to enhance the clearance of middle molecular weight substances during dialysis. However, HDF i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 18 publications
0
4
0
Order By: Relevance
“…The removal of middle molecules, such as β2-microglobulin (β2M), and of protein-bound toxins, such as indoxylsulphate, is rather poor with conventional low-flux dialysis, whereas these contribute probably most to uraemic toxicity [ 1 , 2 ]. In an attempt to reduce inflammation and thus cardiovascular toxicity, the use of haemodiafiltration (HDF) or of more open membranes has been promoted to enhance clearance of middle molecular weight substances during dialysis [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The removal of middle molecules, such as β2-microglobulin (β2M), and of protein-bound toxins, such as indoxylsulphate, is rather poor with conventional low-flux dialysis, whereas these contribute probably most to uraemic toxicity [ 1 , 2 ]. In an attempt to reduce inflammation and thus cardiovascular toxicity, the use of haemodiafiltration (HDF) or of more open membranes has been promoted to enhance clearance of middle molecular weight substances during dialysis [ 3 ].…”
Section: Introductionmentioning
confidence: 99%
“…The advantages of high-efficiency HDF are less evident in older patients with shorter life expectancy, in which HD may be a reasonable choice, in particular when residual renal function is present; these patients may fail compensating for albumin loss, and shorter life expectancy makes it unlikely that they will develop dialysis-related amyloidosis, which generally takes at least ten years to become clinically evident [ 100 , 101 , 102 , 103 , 104 , 105 ].…”
Section: Good Nutritional Status Good Clinical Condition Low Mismentioning
confidence: 99%
“…10 Compared with ultrafiltration and nanofiltration membranes used in wastewater treatment, PES hollow fiber membranes used for hemodialysis require an outer surface with a large pore size to improve flux and an inner surface with a small pore size to achieve medium cut-off and high cut-off. 11,12 Hollow fiber membranes are often prepared through a dry-jet wet spinning process, in which the dope solution and bore solution are extruded from the spinneret to the coagulation bath through the air gap. The phase separation of the dope solution is driven by the nonsolvent action of the bore fluid and external coagulation bath.…”
Section: Introductionmentioning
confidence: 99%
“…Polyether sulfone (PES) hollow fiber membranes are widely used in hemodialysis applications owing to their excellent chemical and thermal stability and biocompatibility 10 . Compared with ultrafiltration and nanofiltration membranes used in wastewater treatment, PES hollow fiber membranes used for hemodialysis require an outer surface with a large pore size to improve flux and an inner surface with a small pore size to achieve medium cut‐off and high cut‐off 11,12 . Hollow fiber membranes are often prepared through a dry‐jet wet spinning process, in which the dope solution and bore solution are extruded from the spinneret to the coagulation bath through the air gap.…”
Section: Introductionmentioning
confidence: 99%